Clinical Trial Update: CKD-337 Drug Interaction Study [Phase 1]

View source ↗

Summary

CKD-337 underwent a Phase 1 drug interaction study sponsored by Chong Kun Dang Pharmaceutical; the trial in participants with hyperlipidemia (Fredrickson Type I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• CKD-337

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Dyslipidemia (Fredrickson Type Ⅱa), Dyslipidemia (Fredrickson Type Ⅱb) | Phase 1 | Status: COMPLETED